Endo to buy Par Pharma for about $8 billion
May 18, 2015 at 07:59 AM EDT
Endo International agrees to buy Par Pharmaceutical Holdings from private-equity firm TPG for about $8 billion in cash and stock.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.